1. Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
   Hee Sang Hwang et al, 2021, Cancer Research and Treatment CrossRef
2. Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)—A Necessity for Future ADC Research and Development
   Manar Hammood et al, 2021, Pharmaceuticals CrossRef
3. Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
   Reena Nair et al, 2023, Frontiers in Oncology CrossRef
4. Outcome of Diffuse Large B-Cell Lymphoma with First-line Chemotherapy
   Zulfia Zinat Chowdhury et al, 2021, Haematology Journal of Bangladesh CrossRef
5. Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL
   Felix Korell et al, 2020, Cells CrossRef
6. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma
   Mathew R. Schnorenberg et al, 2023, ACS Nano CrossRef
7. Radiotherapy dose de-escalation in patients with high grade non-Hodgkin lymphoma in a real-world clinical practice
   Budhi Singh Yadav et al, 2023, Radiation Oncology Journal CrossRef
8. DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
   Damir Vrabac et al, 2021, Scientific Data CrossRef
9. The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells
   Giuseppe Ingravallo et al, 2022, Diagnostics CrossRef
10. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway
    Shi Tao et al, 2022, Molecular and Cellular Biochemistry CrossRef
11. CAR T-cell immunotherapy of B-cell malignancy: the story so far
    Leena Halim et al, 2020, Therapeutic Advances in Vaccines and Immunotherapy CrossRef
12. Оптимизация терапии у пациентов с впервые диагностированной диффузной В-крупноклеточной лимфомой: эффективность и безопасность программы R-SD-EPOCH ± HDMTX в рамках одноцентрового нерандомизированного проспективного клинического исследования (предварительные результаты)
    Marat Albertovich Mingalimov et al, 2024, Clinical Oncohematology CrossRef
13. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review
    Mohammad Sadegh Fallahi et al, 2024, Current Cancer Therapy Reviews CrossRef
14. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre 18F-FDG PET/CT and bone marrow biopsy evaluation study
    Andrej Doma et al, 2024, Radiology and Oncology CrossRef
15. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
    Ajay Gogia et al, 2021, Frontiers in Oncology CrossRef
16. PET/CT Imaging of Lymphoma Outside the Western World
    Raoul Gabus et al, 2021, Lymphoma CrossRef
17. Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
    Jing Qi et al, 2022, Journal of Oncology CrossRef
18. Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
    Barbara Jezeršek Novaković et al, 2021, Therapeutics and Clinical Risk Management CrossRef
19. Making Rituximab Directly Cytotoxic for Substantial Improvement in Therapeutic Efficacy
    Xinjian Chen, 2018, EMJ Hematology CrossRef
20. Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
    Marcus Bauer et al, 2021, Cancers CrossRef